Cargando…
VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer
BACKGROUND: Anti-angiogenesis therapy that targets VEGF is one of the important treatment strategies in advanced ovarian cancer. However, depending on the pharmaceutical agent, treatment can have undesirable side effects. SEMA4D has recently gained interest for its role in promoting angiogenesis. He...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751932/ https://www.ncbi.nlm.nih.gov/pubmed/29308068 http://dx.doi.org/10.1186/s11658-017-0058-9 |